Want to join the conversation?
Nomura analyst Steven Chubak questions $JPM whether the fee income outlook of $50Bil is a fair assessment and if it is relatively achievable. CFO Marianne Lake says that t is going to be market dependent. 1H16 market is a challenge, while 2H16 is better. There are puts and takes, but net net 1H16 will be relatively flat YoverY, a reasonable case.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.